| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.088 | 0.09 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.09 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.09 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.09 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.09 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.31 | 0.1 |